Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BXP, Inc. stock logo
BXP
BXP
$68.11
+0.9%
$67.93
$54.22
$90.11
$10.78B1.161.34 million shs1.39 million shs
Haleon PLC Sponsored ADR stock logo
HLN
Haleon
$10.35
-0.2%
$10.72
$8.25
$11.42
$46.52B0.319.39 million shs17.83 million shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BXP, Inc. stock logo
BXP
BXP
-1.73%-5.08%+0.28%+0.77%+9.55%
Haleon PLC Sponsored ADR stock logo
HLN
Haleon
-0.24%-1.15%-8.80%+1.82%+25.42%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BXP, Inc. stock logo
BXP
BXP
3.8015 of 5 stars
3.21.02.51.82.41.70.6
Haleon PLC Sponsored ADR stock logo
HLN
Haleon
2.1932 of 5 stars
2.43.02.50.01.90.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BXP, Inc. stock logo
BXP
BXP
2.46
Hold$79.5416.78% Upside
Haleon PLC Sponsored ADR stock logo
HLN
Haleon
2.73
Moderate Buy$12.3319.08% Upside

Current Analyst Ratings Breakdown

Latest N4P, HELD, HLN, and BXP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/23/2025
BXP, Inc. stock logo
BXP
BXP
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$85.00 ➝ $86.00
6/23/2025
BXP, Inc. stock logo
BXP
BXP
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Neutral$72.00 ➝ $78.00
5/27/2025
BXP, Inc. stock logo
BXP
BXP
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$75.00 ➝ $71.00
5/27/2025
Haleon PLC Sponsored ADR stock logo
HLN
Haleon
BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/27/2025
Haleon PLC Sponsored ADR stock logo
HLN
Haleon
BNP Paribas Exane
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Outperform$13.40
5/19/2025
BXP, Inc. stock logo
BXP
BXP
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$80.00 ➝ $78.00
5/9/2025
Haleon PLC Sponsored ADR stock logo
HLN
Haleon
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$11.25
5/6/2025
Haleon PLC Sponsored ADR stock logo
HLN
Haleon
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
5/5/2025
BXP, Inc. stock logo
BXP
BXP
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$80.00 ➝ $68.00
4/15/2025
BXP, Inc. stock logo
BXP
BXP
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$100.00 ➝ $85.00
(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BXP, Inc. stock logo
BXP
BXP
$3.41B3.16$7.59 per share8.97$50.21 per share1.36
Haleon PLC Sponsored ADR stock logo
HLN
Haleon
$14.35B3.24$0.50 per share20.82$4.58 per share2.26
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BXP, Inc. stock logo
BXP
BXP
$14.27M-$0.02N/A9.375.61-0.16%3.72%1.16%7/29/2025 (Estimated)
Haleon PLC Sponsored ADR stock logo
HLN
Haleon
$1.84B$0.3926.5421.122.9612.86%17.65%8.58%7/2/2025 (Estimated)

Latest N4P, HELD, HLN, and BXP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/29/2025Q2 2025
BXP, Inc. stock logo
BXP
BXP
$1.67N/AN/AN/A$845.09 millionN/A
4/29/2025Q1 2025
BXP, Inc. stock logo
BXP
BXP
$1.65$1.64-$0.01$1.64$833.89 million$865.22 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BXP, Inc. stock logo
BXP
BXP
$3.925.76%N/AN/A N/A
Haleon PLC Sponsored ADR stock logo
HLN
Haleon
$0.252.42%N/A64.10%N/A

Latest N4P, HELD, HLN, and BXP Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/20/2025
BXP, Inc. stock logo
BXP
BXP
quarterly$0.985.47%6/30/20256/30/20257/31/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BXP, Inc. stock logo
BXP
BXP
2.04
4.23
4.23
Haleon PLC Sponsored ADR stock logo
HLN
Haleon
0.53
0.98
0.78

Institutional Ownership

CompanyInstitutional Ownership
BXP, Inc. stock logo
BXP
BXP
98.72%
Haleon PLC Sponsored ADR stock logo
HLN
Haleon
6.67%

Insider Ownership

CompanyInsider Ownership
BXP, Inc. stock logo
BXP
BXP
1.35%
Haleon PLC Sponsored ADR stock logo
HLN
Haleon
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
BXP, Inc. stock logo
BXP
BXP
780158.32 million156.19 millionOptionable
Haleon PLC Sponsored ADR stock logo
HLN
Haleon
24,5614.49 billionN/ANot Optionable

Recent News About These Companies

Haleon publiceert update stemrechten voor aandeelhouders
HLN - Haleon PLC ADR Sustainability - Morningstar
HLN - Haleon PLC ADR Valuation - Morningstar
HALEON APPOINTS CARL HANEY AS CHIEF R&D OFFICER
Haleon: Business Is Doing Fine, But It's Fully Priced
Kalkine : Haleon’s Surge on NYSE Composite Right Now
Haleon meldt aandelentransacties door leidinggevenden

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
BXP stock logo

BXP NYSE:BXP

$68.11 +0.64 (+0.95%)
Closing price 03:59 PM Eastern
Extended Trading
$68.11 +0.00 (+0.00%)
As of 06:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Boston Properties, Inc. (NYSE: BXP) (BXP or the Company) is the largest publicly traded developer, owner, and manager of premier workplaces in the United States, concentrated in six dynamic gateway markets - Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. BXP has delivered places that power progress for our clients and communities for more than 50 years. BXP is a fully integrated real estate company, organized as a real estate investment trust (REIT). Including properties owned by joint ventures, BXP's portfolio totals 53.3 million square feet and 188 properties, including 10 properties under construction/redevelopment. BXP's properties include 167 office properties, 14 retail properties (including two retail properties under construction/redevelopment), six residential properties (including one residential property under construction) and one hotel. BXP is well-known for its inhouse building management expertise and responsiveness to clients' needs. BXP holds a superior track record of developing premium Central Business District (CBD) office buildings, successful mixed-use complexes, suburban office centers and build-to-suit projects for a diverse array of creditworthy clients. BXP actively works to promote its growth and operations in a sustainable and responsible manner. BXP has earned a twelfth consecutive GRESB Green Star recognition and the highest GRESB 5-star Rating. BXP, an S&P 500 company, was founded in 1970 by Mortimer B. Zuckerman and Edward H. Linde and became a public company in 1997.

Haleon stock logo

Haleon NYSE:HLN

$10.35 -0.02 (-0.19%)
Closing price 03:59 PM Eastern
Extended Trading
$10.43 +0.08 (+0.73%)
As of 06:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.